Molecule Name |
DB00140
|
DrugBank Groups |
Approved
|
Cluster No |
25
|
Smiles |
O=C3(N=C2(N(C1(=C(C=C(C)C(=C1)C)N=C2C(N3)=O))CC(O)C(O)C(O)CO))
|
Download |
mol2, pdbqt
|
TPSA |
155,05
|
Non-H Atoms |
27
|
Non-C/H Atoms |
10
|
Metal-Atoms |
0
|
Electronegative Atoms |
10
|
Stereo Centers |
3
|
Rotatable Bonds |
5
|
Rings Closures |
3
|
Small Rings |
3
|
Aromatic Rings |
1
|
Aromatic Atoms |
6
|
sp3-Atoms |
11
|
Symmetric atoms |
0
|
cLogS |
-2,427
|
MW |
376,368
|
cLogP |
-2,0663
|
HBA |
10
|
HBD |
5
|
Ro5 violations |
0
|
Druglikeness |
6,1929
|
DrugScore |
0,874119784848679
|
Mutagenic |
none
|
Tumorigenic |
none
|
Reproductive Effective |
none
|
Irritant |
none
|
Blood-Brain Barrier |
BBB-
|
Human Intestinal Absorption |
HIA+
|
Caco-2 Permeability |
Caco2-
|
P-glycoprotein Substrate |
Substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor 2 |
Non-inhibitor
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Aqueous solubility |
-3,6043
|
Caco-2 Permeability 2 |
0,2634
|
Subcellular localization |
Mitochondria
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 2D6 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Non-substrate
|
CYP450 1A2 Inhibitor |
Inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Inhibitor
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition 2 |
Non-inhibitor
|
AMES Toxicity |
Non AMES toxic
|
Carcinogens |
Non-carcinogens
|
Fish Toxicity |
Low FHMT
|
Fish Toxicity (pLC50, mg/L) |
1,7396
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity (pIGC50, ug/L) |
0,3393
|
Honey Bee Toxicity |
Low HBT
|
Biodegradation |
Not ready biodegradable
|
Acute Oral Toxicity |
IV
|
Rat Acute Toxicity (LD50, mol/kg) |
1,6067
|
Carcinogenicity (Three-class) |
Non-required
|